14-33929099-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_022073.4(EGLN3):āc.591A>Gā(p.Glu197=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00926 in 1,614,086 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0082 ( 6 hom., cov: 33)
Exomes š: 0.0094 ( 99 hom. )
Consequence
EGLN3
NM_022073.4 synonymous
NM_022073.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.11
Genes affected
EGLN3 (HGNC:14661): (egl-9 family hypoxia inducible factor 3) Enables peptidyl-proline 4-dioxygenase activity. Involved in several processes, including activation of cysteine-type endopeptidase activity involved in apoptotic process; peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia. Located in cytosol and nucleus. Implicated in renal cell carcinoma. Biomarker of clear cell renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 14-33929099-T-C is Benign according to our data. Variant chr14-33929099-T-C is described in ClinVar as [Benign]. Clinvar id is 783045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.11 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGLN3 | NM_022073.4 | c.591A>G | p.Glu197= | synonymous_variant | 3/5 | ENST00000250457.9 | |
EGLN3 | NM_001308103.2 | c.309A>G | p.Glu103= | synonymous_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGLN3 | ENST00000250457.9 | c.591A>G | p.Glu197= | synonymous_variant | 3/5 | 1 | NM_022073.4 | P1 | |
EGLN3 | ENST00000553215.5 | c.309A>G | p.Glu103= | synonymous_variant | 3/5 | 1 | |||
EGLN3 | ENST00000487915.6 | c.237A>G | p.Glu79= | synonymous_variant | 6/6 | 5 | |||
EGLN3 | ENST00000556785.1 | n.355A>G | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00821 AC: 1250AN: 152188Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
1250
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00926 AC: 2327AN: 251350Hom.: 10 AF XY: 0.00976 AC XY: 1326AN XY: 135826
GnomAD3 exomes
AF:
AC:
2327
AN:
251350
Hom.:
AF XY:
AC XY:
1326
AN XY:
135826
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00937 AC: 13695AN: 1461780Hom.: 99 Cov.: 31 AF XY: 0.00972 AC XY: 7066AN XY: 727196
GnomAD4 exome
AF:
AC:
13695
AN:
1461780
Hom.:
Cov.:
31
AF XY:
AC XY:
7066
AN XY:
727196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00821 AC: 1250AN: 152306Hom.: 6 Cov.: 33 AF XY: 0.00858 AC XY: 639AN XY: 74478
GnomAD4 genome
AF:
AC:
1250
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
639
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at